Magnesium oral spray for chronic cough
Part of Lungs & breathing clinical trials.
This trial tests a magnesium salt oral spray (SC0032) for adults whose chronic cough has not responded to treatment or has no clear cause. It aims to see if the spray can reduce coughing frequency and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You have had a chronic cough (lasting >8 weeks) for at least 6 months.
- You cough at least 8 times per hour (based on a 24-hour monitor).
- You rate your cough severity as at least 40 out of 100.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use birth control if needed.
- You do not have other major lung diseases like COPD, asthma (uncontrolled), or lung scarring.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called HW091077 for people with chronic cough that doesn't improve with usual treatments or has no clear cause. The drug targets a protein involved in the cough reflex and may help reduce coughing.
This trial tests whether an extended-release medication called nalbuphine can reduce coughing in people with chronic cough that hasn't improved with other treatments. You may be eligible if you've had a persistent cough for at least a year and have already tried treatments for conditions that could cause it.
This study tests a behavior-based therapy to help you gain control over a persistent cough that hasn't responded to other treatments. You will learn techniques to reduce coughing during a 4-week program.
This study tests two treatments for a chronic cough that doesn't get better with usual care. You may receive a medication that affects the nerves (a neuromodulator), a cough control therapy (special exercises and education), both, or neither. The goal is to see which approach helps reduce coughing.
This trial tests a smartphone app and a smartwatch to help people with chronic cough that hasn't improved with standard care. You'll wear a watch to track your cough and use the app to learn management techniques.
This 24-week study tests whether a new medicine called BLU-5937 can help adults whose chronic cough hasn't improved with standard treatments. Chronic cough that lasts a year or longer can seriously affect quality of life, and this trial explores whether this drug might provide relief.
Hear when a new Refractory Chronic Cough and Unexplained Chronic Cough trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.